| Line 1: |
Line 1: |
| − | {{unfinished}}
| + | #REDIRECT[[:Category:Rhabdoviridae]] |
| − | | |
| − | {{toplink
| |
| − | |linkpage =Viruses
| |
| − | |linktext =VIRUSES
| |
| − | |pagetype=Bugs
| |
| − | }}
| |
| − | <br>
| |
| − | | |
| − | =Introduction=
| |
| − | Rabies is a neurological killer that has evolved a fool-proof technique of transmission, and it cleverly evades the species barrier to present a potent threat to mammalian life. While the simplicity of the virus insures its transmission, it also contributes to its weakness: its monoclonal antigenicity means that a single vaccination covers all strains of the disease. Though rabies is considered endemic in parts of the developed and undeveloped world, vaccination schemes have rendered the disease controllable to a satisfactory degree. Nonetheless, infection is still largely fatal and the disease should not be taken lightly.
| |
| − | | |
| − | =Morphology=
| |
| − | *Large, enveloped, negative-sense RNA virus
| |
| − | *'''Bullet-shaped''' with short glycoprotein spikes
| |
| − | | |
| − | =Types and Subtypes=
| |
| − | Two Genera:
| |
| − | #Lyssaviruses: 7 genotypes | |
| − | ##'''Genotype 1''' is '''classical rabies'''
| |
| − | ##Genotypes 2-7 more limited in distribution
| |
| − | ##Genotype 4 infects '''insectivorous bats'''
| |
| − | #Vesiculoviruses are all '''exotic''' to the UK:
| |
| − | ##Vesicular Stomatitis Virus
| |
| − | ##Ephemeral Fever
| |
| − | ##Fish Rhabdoviruses, such as viral hemorrhagic syndrome and infectious haematopoetic necrosis virus
| |
| − | | |
| − | =Virulence and Pathogenesis=
| |
| − | *Rabies is moderately resistant: it can survive well in dark places at low temperatures for several days
| |
| − | *Infection occurs through a '''penetrating bite''' in which virus is transmitted via '''saliva'''
| |
| − | *'''Incubation''' period is variable but can be long (10 days to 12 months), and increases with distance of the bite to the CNS
| |
| − | **80% show signs within 4 months
| |
| − | *Primary replication of the virus occurs in the '''muscle'''
| |
| − | *The virus gains access to nervous tissue and travels toward the '''brain''', where it continues to replicate
| |
| − | *It then migrates down cranial nerves to infect salivary glands and the cornea
| |
| − | *Virus is shed in '''saliva''' and '''tears''' and can be shed BEFORE the onset of classical signs
| |
| − | *The onset of clinical signs in dogs and cats includes:
| |
| − | **Behavioral changes
| |
| − | **Pyrexia
| |
| − | **Salivation
| |
| − | **Dilation of pupils
| |
| − | *Two forms of the virus exist:
| |
| − | **'''Furious''' form:
| |
| − | ***Common to cats and dogs
| |
| − | ***Abnormal aggression, salivation, and attack without provocation
| |
| − | ***Disordered wandering
| |
| − | ***Incoordination, convulsions, coma and death within 3-10 days
| |
| − | **'''Dumb''' form
| |
| − | ***May or may not follow Furious form
| |
| − | ***Common to ruminants and horses
| |
| − | ***Ruminal tympany, tenesmus, diarrhoea
| |
| − | ***Paralysis of lower jaw, drooling saliva, tremors and progressive paralysis
| |
| − | ***In dogs, a change in voice may be observed (bellowing)
| |
| − | *Human infection is characterized by '''hydrophobia'''
| |
| − | | |
| − | =Epidemiology=
| |
| − | *Rabies is a '''NOTIFIABLE''' zoonosis
| |
| − | *Rabies is found worldwide, though currently considered exotic to the UK and Australia
| |
| − | Host Range:
| |
| − | *All mammals are susceptible
| |
| − | **Very susceptible: foxes, jackals, wolves
| |
| − | **Susceptible (10,000x virus necessary to infect): cats, rodents, bats, skunks, cattle, mongooses
| |
| − | **Moderately susceptible (100,000x virus necessary to infect): dogs, sheep, goats, horses, primates
| |
| − | *Isolates can show to some species specificity in their reservoir host
| |
| − | Reservoir species by region:
| |
| − | {| style="width:60%; height:200px" border="1" align=center
| |
| − | !'''Region'''
| |
| − | !'''Reservoir Species'''
| |
| − | |-
| |
| − | |Europe
| |
| − | |Red fox
| |
| − | |-
| |
| − | |Russia, Turkey, Middle East
| |
| − | |Dog, Raccoon
| |
| − | |-
| |
| − | |USA
| |
| − | |Raccoon, Fox, Skunk
| |
| − | |-
| |
| − | |Africa
| |
| − | |Dog, Jackal, Mongoose
| |
| − | |-
| |
| − | |Asia
| |
| − | |Dog, Mongoose
| |
| − | |-
| |
| − | |South America
| |
| − | |Dog, Vampire bat
| |
| − | |-
| |
| − | |Worldwide
| |
| − | |Insectivorous Bats
| |
| − | |}
| |
| − | *The current position of DEFRA holds bat lyssaviruses to be present in the UK
| |
| − | *Human infection and death an occur after infection with bat rabies
| |
| − | **Nocturnal bat bites account for 50% of human cases in the USA
| |
| − | *Humans develop disease but excrete little virus
| |
| − | *Immune recovered animals are rare, but are not shown to be infections
| |
| − | | |
| − | =Diagnosis=
| |
| − | *'''Isolate''' and monitor for clinical signs
| |
| − | *In the field:
| |
| − | **Remove brain core sample via straw through occipital foramen in the direction of an eye
| |
| − | **Place contents in a 50% glyerol/PBS for FAT or virus isolation, or in 10% formaldehyde for histology
| |
| − | **Whole head can also be removed and sent to lab
| |
| − | *In the lab:
| |
| − | **'''Fluorescent Antibody Test (FAT)''' on smears or frozen sections of hippocampus or cerebellum should show presence of Negri bodies
| |
| − | ***Being replaced by testing for monoclonal antibodies to nucleoprotein
| |
| − | **Histological detection of Negri bodies using Mann's or silver stains
| |
| − | **Intracerebral inoculation of mice followed by FAT testing of brain smears of affected mice
| |
| − | **RT-PCR on brain or saliva can be performed to determine genotype
| |
| − | | |
| − | =Rabies Control=
| |
| − | For countries where rabies is considered exotic:
| |
| − | *6 month quarantine of carnivores and ruminants (Norway, Sweden, Portugal, Australia, New Zealand)
| |
| − | *In the UK, this has been replaced by the '''Pet Travel Scheme''' ([http://www.defra.gov.uk/animalh/quarantine/index.htm PETS])
| |
| − | For virus-endemic countries:
| |
| − | #Control in pets:
| |
| − | #*Annual Vaccination:
| |
| − | #**Antigenicity allows a single antigenic type to vaccinate
| |
| − | #**'''Inactivated virus''' or '''canarypox''' recombinant viruses
| |
| − | #*Control of stray population
| |
| − | #*Muzzling in public
| |
| − | #Control of wildlife reservoir hosts:
| |
| − | #*Feeding vaccinated bait
| |
| − | #*Secondary consequence of increasing reservoir host population (eg European foxes)
| |
| − | #Control in humans
| |
| − | ##Prevention by vaccination with a single booster if bitten
| |
| − | ##*The current vaccine is grown in human diploid cells (HDCV) and is BPL-inactivated, and therefore costly
| |
| − | ##*Developing countries utilize older vaccines passaged from a 1939 case ("Flury" vaccines)
| |
| − | ##If bitten and unvaccinated:
| |
| − | ##*Clean and disinfect wound
| |
| − | ##*Human '''anti-rabies immunoglobulin''' administered around bite
| |
| − | ##*Intramuscular vaccination program: 2 dose-1 dose-1 dose at 0, 7, and 14 days post-bite
| |
| − | | |
| − | For more on Rabies control in Europe, see [http://www.who-rabies-bulletin.org/About_Rabies/Control.aspx here]
| |